Top Story

JDRF forms new research advisory committee

February 13, 2016

A newly formed external research advisory committee of nationally known diabetes experts will guide the JDRF on policy matters and research-related issues to help the organization further its strategic plan, according to a press release.

The committee, according to JDRF, will advise the organization on matters of policy pertaining to research philosophy and procedures to help the organization be more effective in its efforts to cure, prevent and treat type 1 diabetes.

In the Journals

Top 5 online stories posted in January

February 12, 2016
Endocrine Today compiled a list of the top five news reports posted in January. Healio.com/Endocrinology readers were interested in changes in fat distribution…

CMS extends 2015 EHR meaningful use attestation deadline

February 12, 2016
CMS has extended the deadline to attest to meaningful use of electronic health records for 2015, according to an email from the agency.Providers in the Medicare &…
In the Journals

High normal range atrial natriuretic peptide may reduce insulin resistance risk in middle age

February 12, 2016
Exposure during middle age to atrial natriuretic peptide within the high normal range appears to be associated with a reduced risk for insulin resistance after 16.5…

Senate Health Committee passes Advancing Research for Neurological Diseases Act of 2015

February 12, 2016
The Senate Health Committee passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849)” on Tuesday, which will establish a national…
More News Headlines »

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Meeting News CoverageVideo

VIDEO: Weight loss tips from the experts — Big changes lead to big results

November 23, 2015
More »

Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic eye disease is one of the most common causes of vision loss in the United States. As the rates of diabetes…
More »
Current Issues
View the Current Issues
morganatic-roan morganatic-roan